Pharmasaga Visits International Pharmaceutical Companies
[translated from Chinese]
By Reporter 吳典叡 / Comprehensive Report
The 2025 BIO International Convention was held from June 16 to 19 in Boston, USA. The National Science and Technology Council (NSTC) today (18th) pointed out that the eight startup companies exhibiting were all teams subsidized by the NSTC's Science and Technology Innovation Program, covering fields such as AI drug development, and cancer and neurodegenerative disease treatments, representing Taiwanese teams with R&D depth and market potential in recent years. Among them, Pharmasaga successfully advanced to the finals of the exhibition's most prominent competition, the Start-Up Stadium, amidst fierce competition from hundreds of global startups, demonstrating the strength and potential of Taiwan's biotech innovation on the international stage.
The NSTC stated that in leading the eight biomedical startups to the BIO exhibition, in addition to conducting business partnering at the exhibition, they also arranged field visits and technical exchanges with accelerator MIT The Engine and international pharmaceutical company Novo Nordisk, commencing preliminary discussions on clinical trials, early development, and licensing cooperation.
The NSTC added that the eight exhibiting startup companies, all subsidized by the NSTC's Science and Technology Innovation Program, cover areas such as AI drug development, and cancer and neurodegenerative disease treatments, representing teams with R&D depth and market potential in Taiwan in recent years.
Specifically, Pharmasaga, which develops small-molecule novel drugs for diabetes treatment, successfully advanced to the finals of the exhibition's most prominent competition, the Start-Up Stadium, amidst competition from hundreds of global startups. This showcases the strength and potential of Taiwan's biotech innovation on the international stage. The competition is one of the most closely watched highlights of the BIO exhibition, attracting hundreds of top startups from around the world annually and boasting high international visibility.